In another study, TAZ was shown to transcriptionally upregulate PD-L1 via an upstream mechanism that involves tumor-cell-derived lactate and GPCR81 (also known as hydroxycarboxylic acid receptor 1, HCAR1) signaling [26]. The gene discussed is HCAR1; the disease is neoplasm.